Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aitia
AddedFeb 15, 2024
UpdatedJun 18, 2026
Aitia

Aitia

Series D

Aitia, a leader in Causal AI and Digital Twins, accelerates drug discovery and R&D in various diseases with global partners.

HQ
Somerville, MA, US
Founded
2000
Overview
Compare
Fundraising
Employees
Website

Aitia, founded with a mission to revolutionize drug discovery, specializes in the application of Causal AI and Digital Twins technology. The company leverages multi-omic patient data, high-performance computing, and causal learning to uncover hidden biological mechanisms of diseases. Aitia's Gemini Digital Twins are instrumental in accelerating research and development in oncology, neurodegenerative disorders, and immunology, aiming to discover novel therapies and expedite the drug development process.

Notable figures associated with Aitia include CEO Colin Hill, who actively promotes the innovative use of AI in drug discovery. The company has formed significant collaborations, such as with Servier to focus on Parkinson’s disease. Aitia's groundbreaking work in Causal AI and Digital Twins has positioned it as a leader in the biotech industry, driving forward the next generation of breakthrough drugs and making a substantial impact on global healthcare research and development.

Aitia - Similar Companies

ConcertAI logo

ConcertAI

concertai.com

Pathos AI logo

Pathos AI

pathos.com

Insitro logo

Insitro

insitro.com

BioAI Health logo

BioAI Health

bioaihealth.com

Insilico Medicine logo

Insilico Medicine

insilico.com

Owkin logo

Owkin

owkin.com

Gatc Health logo

Gatc Health

gatchealth.com

Enable Medicine logo

Enable Medicine

enablemedicine.com

Cognaisent logo

Cognaisent

cognaisent.com

Ordaos logo

Ordaos

ordaos.bio

TandemAI logo

TandemAI

tandemai.com

Biotia logo

Biotia

biotia.io

Triomics logo

Triomics

triomics.com

Noetik logo

Noetik

noetik.ai

Ambit.AI logo

Ambit.AI

ambit.ai

Aitia - Quick Facts

Who are Aitia's competitors?

Companies similar to Aitia include ConcertAI, Pathos AI, Insitro and BioAI Health.

When was Aitia founded?

Aitia was founded in 2000.

Where is Aitia's headquarters located?

Aitia's headquarters is located in Somerville, MA, US.

When was Aitia's last funding round?

Aitia's most recent funding round was for $23M (USD) in July 2019.

How much has Aitia raised to-date?

As of Jul 9, 2019, Aitia has raised a total of $77.3M (USD).

How many employees does Aitia have?

Aitia has 88 employees as of Feb 5, 2024.

Aitia - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Revenue
  • Recurring
Main Product
  • AI Software
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software